Yayınlar & Eserler

Yayın Ağı
Makaleler 58
Tümü (58)
SCI-E, SSCI, AHCI (54)
SCI-E, SSCI, AHCI, ESCI (57)
Scopus (58)
TRDizin (6)

1. Percutaneous Closure of Pseudoaneurysm of Arcus Aorta With Atrial Septal Defect Occluder Device

MURAT S. N., Koçak D. Y., Çeliksöz M., Yeniköy B.
Catheterization and Cardiovascular Interventions , cilt.106, sa.3, ss.1840-1842, 2025 (SCI-Expanded, Scopus)

2. Reply to Letter to the Editor: “Factors Influencing the Risk of No-Reflow Development”

ÇELİK İ. E., Yarlıoğlu M., Barutçu O., Akgün O., DURAN M., YORULMAZ Ş., et al.
Anatolian Journal of Cardiology , cilt.28, sa.5, ss.257, 2024 (SCI-Expanded, Scopus)

3. Platelet activating factor acetylhydrolase is associated with cardiac valvular calcification in dialysis patients

Bolat S., Fidancı V., ELÇİK D., Tomar Ö. K., MURAT S. N., DURANAY M., et al.
Turkish Journal of Biochemistry , cilt.49, sa.2, ss.274-282, 2024 (SCI-Expanded, Scopus, TRDizin)

4. Concurrent Percutaneous Intervention for Simultaneous Acute Myocardial Infarction and Acute Bifurcated Graft Thrombosis of Lower Extremities Akut Bacak İskemisi ve Akut Miyokard Enfarktüsü için Eş Zamanlı Perkütan Girişim

ÇELİK İ. E., ÖZTÜRK S., Yarlıoğlu M., DURAN M., MURAT S. N.
Anatolian Journal of General Medical Research , cilt.34, sa.1, ss.106-109, 2024 (Scopus, TRDizin)

5. The Association Between Atherogenic Index of Plasma and No-Reflow Phenomenon in Acute Coronary Syndrome

ÇELİK İ. E., ÖZTÜRK S., Yarlıoğlu M., Barutçu O., Akgün O., DURAN M., et al.
Anatolian Journal of Cardiology , cilt.27, ss.712-719, 2023 (SCI-Expanded, Scopus, TRDizin)

6. Placement of permanent pacemaker in a patient with venous anomaly through the right subclavian vein Implantação de pacemaker definitivo pela veia subclávia num doente com anomalia venosa

ÇELİK İ. E., DURAN M., Yarlıoglu M., MURAT S. N.
Revista Portuguesa de Cardiologia , cilt.42, sa.1, ss.75-76, 2023 (SCI-Expanded, Scopus)

7. Assessment of Tp–e interval, Tp–e/QT, and Tp-e/QTc ratios in patients with acromegaly

ÇELİK İ. E., Firat S. N., Bozkurt U., Yarlioğlu M., DURAN M., MURAT S. N.
Turkish Journal of Medical Sciences , cilt.52, sa.3, ss.809-815, 2022 (SCI-Expanded, Scopus, TRDizin)

8. Severe cardiovascular involvement in a patient with rheumatoid arthritis

Yalcinkaya D., Yarlioglues M., ERGÜN E., ÇELİK İ. E., ÖKSÜZ F., Cicek G., et al.
Kardiologia Polska , cilt.79, sa.5, ss.577-578, 2021 (SCI-Expanded, Scopus)

9. Mitral annular calcification and its severity predict high risk for cardio-embolic stroke in elderly patients with first diagnosed atrial fibrillation

ÖKSÜZ F., Yarlioglues M., DURAN M., ELÇİK D., ÖZTÜRK S., Kılıc A., et al.
Acta Cardiologica , cilt.76, sa.1, ss.56-62, 2021 (SCI-Expanded, Scopus)

10. Diagnosis of Heterotaxy Syndrome in a Patient With Multiple Congenital Cardiac Malformations Using Magnetic Resonance Imaging

MURAT S. N., Yalcinkaya D., Yarlioglues M., YİĞİT H., Bozkurt U., ÇELİK İ. E., et al.
Circulation: Cardiovascular Imaging , cilt.13, sa.9, 2020 (SCI-Expanded, Scopus)

11. CHA2DS2-Vasc score and saphenous vein graft disease in patients with coronary artery bypass graft surgery

Yarlioglues M., ÖKSÜZ F., Yalcinkaya D., DURAN M., MURAT S. N.
Coronary Artery Disease , cilt.31, sa.3, ss.243-247, 2020 (SCI-Expanded, Scopus)

12. Relationship between mild renal dysfunction and coronary artery disease in young patients with stable angina pectoris

DURAN M., ELÇİK D., Inanc M. T., Yarlloglues M., ÇELİK İ. E., ÖKSÜZ F., et al.
Biomarkers in Medicine , cilt.14, sa.6, ss.433-440, 2020 (SCI-Expanded, Scopus)

13. Concominant hypertrophic and takotsubo cardiomyopathy; cardiac magnetic resonance with parametric mapping findings after acute phase

Yalcinkaya D., Yarlioglues M., YİĞİT H., DURAN M., MURAT S. N.
International Journal of Cardiovascular Imaging , cilt.36, sa.3, ss.543-544, 2020 (Scopus)

14. Possible Effect of Alcohol Consumption on Aortic Dilatation by Inducing Renin–Angiotensin–Aldosterone System

Yarlioglues M., Yalcinkaya D., ÖKSÜZ F., ÇELİK İ. E., DURAN M., MURAT S. N.
Angiology , cilt.70, sa.10, ss.978-979, 2019 (SCI-Expanded, Scopus)

15. Ethnicity and the Evaluation of Anthropometric Measurements

Yarlioglues M., Yalcinkaya D., DURAN M., MURAT S. N.
Angiology , cilt.70, sa.10, ss.984, 2019 (SCI-Expanded, Scopus)

16. Risk factors for coronary artery disease in young patients with stable angina pectoris

DURAN M., ELÇİK D., MURAT S. N., ÖKSÜZ F., ÇELİK İ. E.
Turkish Journal of Medical Sciences , cilt.49, sa.4, ss.993-998, 2019 (SCI-Expanded, Scopus, TRDizin)

17. Electrocardiographic alterations in patients consuming synthetic cannabinoids

Ozturk H. M., ERDOĞAN M., Alsancak Y., Yarlioglues M., DURAN M., Boztas M. H., et al.
Journal of Psychopharmacology , cilt.32, sa.3, ss.296-301, 2018 (SCI-Expanded, Scopus)

18. The relationship between lymphocyte-to-monocyte ratio and saphenous vein graft patency in patients with coronary artery bypass graft

ÖKSÜZ F., Elcik D., Yarlioglues M., DURAN M., ÖZTÜRK S., ÇELİK İ. E., et al.
Biomarkers in Medicine , cilt.11, sa.10, ss.867-876, 2017 (SCI-Expanded, Scopus)

19. A severe aortic coarctation newly diagnosed during cardiac catheterization in an adult presenting with acute anterior myocardial infarction

Kiliç A., ÇELİK İ. E., DURAN M., MURAT S. N.
Turk Kardiyoloji Dernegi Arsivi , cilt.45, sa.3, ss.300, 2017 (Scopus, TRDizin)

20. The Relationship between Lymphocyte-to-Monocyte Ratio and Bare-Metal Stent In-Stent Restenosis in Patients with Stable Coronary Artery Disease

MURAT S. N., Yarlioglues M., ÇELİK İ. E., KURTUL A., DURAN M., Kilic A., et al.
Clinical and Applied Thrombosis/Hemostasis , cilt.23, sa.3, ss.235-240, 2017 (SCI-Expanded, Scopus)

21. The effect of statin treatment on the prevention of stent mediated flow limited edge dissections during PCI in patients with stable angina

ÖKSÜZ F., Yarlioglues M., YAYLA Ç., CANPOLAT U., MURAT S. N., AYDOĞDU S.
International Journal of Cardiology , cilt.220, ss.365-370, 2016 (SCI-Expanded, Scopus)

22. Association of Neutrophil-to-lymphocyte Ratio with Contrast-induced Nephropathy in Patients with Non-ST-elevation Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention

KURTUL A., Yarlioglues M., DURAN M., MURAT S. N.
Heart Lung and Circulation , cilt.25, sa.7, ss.683-690, 2016 (SCI-Expanded, Scopus)

23. Preprocedural Albumin Levels and Risk of In-Stent Restenosis after Coronary Stenting with Bare-Metal Stent

ÇELİK İ. E., Yarlioglues M., KURTUL A., DURAN M., Koseoglu C., ÖKSÜZ F., et al.
Angiology , cilt.67, sa.5, ss.478-483, 2016 (SCI-Expanded, Scopus)

24. The association of serum procalcitonin level with the no-reflow phenomenon after a primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction

MURAT S. N., KURTUL A., ÇELİK İ. E., DURAN M., Yarlioglues M., Kilic A., et al.
Coronary Artery Disease , cilt.27, sa.2, ss.116-121, 2016 (SCI-Expanded, Scopus)

25. Elevated serum fibrinogen levels and risk of contrast-induced acute kidney injury in patients undergoing a percutaneous coronary intervention for the treatment of acute coronary syndrome

ÇELİK İ. E., KURTUL A., DURAN M., Yarlioglues M., Elcik D., Kilic A., et al.
Coronary Artery Disease , cilt.27, sa.1, ss.13-18, 2016 (SCI-Expanded, Scopus)

26. Usefulness of serum albumin concentration to predict high coronary SYNTAX score and in-hospital mortality in patients with acute coronary syndrome

KURTUL A., MURAT S. N., Yarlioglues M., DURAN M., Ocek A. H., Koseoglu C., et al.
Angiology , cilt.67, sa.1, ss.34-40, 2016 (SCI-Expanded, Scopus)

27. N-Terminal Pro-Brain Natriuretic Peptide Level is Associated with Severity and Complexity of Coronary Atherosclerosis in Patients with Acute Coronary Syndrome

KURTUL A., Yarlioglues M., MURAT S. N., DURAN M., Acikgoz S. K., Sensoy B., et al.
Clinical and Applied Thrombosis/Hemostasis , cilt.22, sa.1, ss.69-76, 2016 (SCI-Expanded, Scopus)

28. Heart failure functional class associated with depression severity but not anxiety severity

Celik E., ÇAY S., Sensoy B., MURAT S. N., ÖKSÜZ F., Cankurt T., et al.
Acta Cardiologica Sinica , cilt.32, sa.1, ss.55-61, 2016 (SCI-Expanded, Scopus)

29. The association of plasma fibrinogen with the extent and complexity of coronary lesions in patients with acute coronary syndrome

KURTUL A., Yarlioglues M., MURAT S. N., DURAN M., ÖKSÜZ F., Koseoglu C., et al.
Kardiologia Polska , cilt.74, sa.4, ss.338-345, 2016 (SCI-Expanded, Scopus)

30. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction

KURTUL A., Yarlioglues M., ÇELİK İ. E., DURAN M., Elcik D., Kilic A., et al.
Coronary Artery Disease , cilt.26, sa.8, ss.706-712, 2015 (SCI-Expanded, Scopus)

31. Procalcitonin as an early predictor of contrast-induced acute kidney injury in patients with acute coronary syndromes who underwent percutaneous coronary intervention

KURTUL A., MURAT S. N., Yarlioglues M., DURAN M., Ocek A. H., ÇELİK İ. E., et al.
Angiology , cilt.66, sa.10, ss.957-963, 2015 (SCI-Expanded, Scopus)

32. Association of total serum antioxidant capacity with the Tei index in echocardiography in patients with microvascular angina

Kilic A., Yarlioglues M., Ercan E. A., DURAN M., Ugurlu M., ÖKSÜZ F., et al.
Coronary Artery Disease , cilt.26, sa.7, ss.620-625, 2015 (SCI-Expanded, Scopus)

33. Mild to Moderate Renal Impairment Is Associated with No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

KURTUL A., MURAT S. N., Yarlioglues M., DURAN M., ÇELİK İ. E., Kilic A.
Angiology , cilt.66, sa.7, ss.644-651, 2015 (SCI-Expanded, Scopus)

34. Predictors of chronic total occlusion in nonculprit artery in patients with acute coronary syndrome: Mean platelet volume and uric acid

KURTUL A., Yarlioglues M., MURAT S. N., ÇELİK İ. E., Demircelik M. B., Ocek A. H., et al.
Angiology , cilt.66, sa.6, ss.553-559, 2015 (SCI-Expanded, Scopus)

35. High sensitive CRP level is associated with intermediate and high syntax score in patients with acute coronary syndrome

Karadeniz M., DURAN M., Akyel A., Yarlıoğlueş M., Öcek A. H., ÇELİK İ. E., et al.
International Heart Journal , cilt.56, sa.4, ss.377-380, 2015 (SCI-Expanded, Scopus)

36. Red Cell Distribution Width Predicts Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome

KURTUL A., Yarlioglues M., MURAT S. N., Demircelik M. B., Acikgoz S. K., Ergun G., et al.
Angiology , cilt.66, sa.5, ss.433-440, 2015 (SCI-Expanded, Scopus)

37. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

KURTUL A., Ocek A. H., MURAT S. N., Yarlioglues M., Demircelik M. B., DURAN M., et al.
Angiology , cilt.66, sa.3, ss.278-285, 2015 (SCI-Expanded, Scopus)

38. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease

KURTUL A., MURAT S. N., Yarlioglues M., DURAN M., Karadeniz M., Ergun G., et al.
Platelets , cilt.26, sa.1, ss.48-52, 2015 (SCI-Expanded, Scopus)

39. Increased neutrophil-to-lymphocyte ratio predicts persistent coronary no-flow after wire insertion in patients with ST-elevation myocardial infarction xundergoing primary percutaneous coronary intervention

KURTUL A., MURAT S. N., Yarlioglues M., DURAN M., ÇELİK İ. E., Kilic A., et al.
Clinics , cilt.70, sa.1, ss.34-40, 2015 (SCI-Expanded, Scopus)

40. Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes

KURTUL A., MURAT S. N., Yarlioglues M., DURAN M., Ergun G., Acikgoz S. K., et al.
American Journal of Cardiology , cilt.114, sa.7, ss.972-978, 2014 (SCI-Expanded, Scopus)

41. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute st-segment elevation myocardial infarction

KURTUL A., Yarlioglues M., MURAT S. N., Ergun G., DURAN M., KASAPKARA H. A., et al.
American Journal of Cardiology , cilt.114, sa.3, ss.342-347, 2014 (SCI-Expanded, Scopus)

42. The relationship between neutrophil/lymphocyte ratio and infarct-related artery patency before mechanical reperfusion in patients with ST-elevation myocardial infarction

KURTUL A., MURAT S. N., Yarlioglues M., DURAN M., Karadeniz M., Ergun G., et al.
Coronary Artery Disease , cilt.25, sa.2, ss.159-166, 2014 (SCI-Expanded, Scopus)

43. The effect of thrombolytic therapy on QT dispersion in acute myocardial infarction and its role in the prediction of reperfusion arrhythmias

ÖRNEK E., DURAN M., ÖRNEK D. H., Demirçelik B., MURAT S. N., KURTUL A., et al.
Nigerian Journal of Clinical Practice , cilt.17, sa.2, ss.183-187, 2014 (SCI-Expanded, Scopus)

44. Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome

KURTUL A., DURAN M., Yarlioglues M., MURAT S. N., Demircelik M. B., Ergun G., et al.
Clinical Cardiology , cilt.37, sa.8, ss.485-492, 2014 (SCI-Expanded, Scopus)

45. Renal impairment and coronary collaterals in patients with acute coronary syndrome

DURAN M., Uysal O., Gunebakmaz O., Yilmaz Y., Vatankulu M., Turfan M., et al.
Herz , cilt.39, sa.3, ss.379-383, 2014 (SCI-Expanded, Scopus)

46. Glomerular filtration rate is associated with burden of coronary atherosclerosis in patients with acute coronary syndrome

DURAN M., Uysal O. K., Gunebakmaz O., Baran O., Turfan M., ÖRNEK E., et al.
Angiology , cilt.65, sa.4, ss.350-356, 2014 (SCI-Expanded, Scopus)

47. Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention

Vatankulu M. A., MURAT S. N., Demircelik B., Turfan M., Sonmez O., DURAN M., et al.
Renal Failure , cilt.35, sa.7, ss.931-935, 2013 (SCI-Expanded, Scopus)

48. Does serum uric acid level affect coronary collaterals in patients with acute coronary syndrome

DURAN M., MURAT S. N., ÖRNEK E.
Angiology , cilt.64, sa.4, ss.325-326, 2013 (SCI-Expanded, Scopus)

49. Red Blood Cell Distribution Width in Saphenous Vein Graft Disease

Akyel A., ÇELİK İ. E., ÖKSÜZ F., ÇAY S., Karadeniz M., KURTUL A., et al.
Canadian Journal of Cardiology , cilt.29, sa.4, ss.448-451, 2013 (SCI-Expanded, Scopus)

50. Evaluation of erectile dysfunction in permanent pacemaker implanted patients with cardiac rhythm disorder prediagnosis

Sagnak L., Ersoy H., Karakoyunlu N., MURAT S. N., Ozok U., TOPALOĞLU H., et al.
Scottish Medical Journal , cilt.58, sa.1, ss.7-11, 2013 (SCI-Expanded, Scopus)

51. Relation between mean platelet volume and severity of atherosclerosis in patients with acute coronary syndromes

MURAT S. N., DURAN M., KALAY N., Gunebakmaz O., Akpek M., DÖĞER C., et al.
Angiology , cilt.64, sa.2, ss.131-136, 2013 (SCI-Expanded, Scopus)

52. Usefulness of mean platelet volume for predicting stroke risk in atrial fibrillation patients

Turfan M., Erdogan E., Ertas G., DURAN M., MURAT S. N., Celik E., et al.
Blood Coagulation and Fibrinolysis , cilt.24, sa.1, ss.55-58, 2013 (SCI-Expanded, Scopus)

53. High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome

DURAN M., ÖRNEK E., MURAT S. N., Turfan M., Vatankulu M. A., Ocak A., et al.
Angiology , cilt.63, sa.6, ss.472-475, 2012 (SCI-Expanded, Scopus)

54. Thrombolytic Treatment of Simultaneous Pulmonary Embolism and Impending Paradoxical Embolism Through a Patent Foramen Ovale: A Different Thrombolytic Regimen

Turfan M., Vatankulu M. A., MURAT S. N., ÖKSÜZ F., DURAN M., ÖRNEK E.
Heart Lung and Circulation , cilt.21, sa.4, ss.225-228, 2012 (SCI-Expanded, Scopus)

55. Late drug eluting stent thrombosis due to acemetacine: Type III Kounis syndrome: Kounis syndrome due to Acemetacine

Akyel A., MURAT S. N., ÇAY S., KURTUL A., Öcek A. H., Cankurt T.
International Journal of Cardiology , cilt.155, sa.3, ss.461-462, 2012 (SCI-Expanded, Scopus)

56. Coronary stenting for acute myocardial infarction in a patient with an anomalous origin of the left main coronary artery

DURAN M., ÖRNEK E., MURAT S. N., Demircelik B., Vatankulu M. A., Turfan M., et al.
Journal of Cardiovascular Medicine , cilt.12, sa.6, ss.436-438, 2011 (SCI-Expanded, Scopus)

57. The relationship between lipoprotein(a) and coronary artery disease, as well as its variable nature following myocardial infarction

ÖRNEK E., MURAT S. N., DURAN M., Turfan M., KURTUL A., Demircelik M. B., et al.
Clinical and Investigative Medicine , cilt.34, sa.1, 2011 (SCI-Expanded, Scopus)

58. Brugada syndrome revealed by propafenone administration

Turfan M., Çelik E., ÖRNEK E., MURAT S. N., DURAN M., Demirçelik M. B.
American Journal of Case Reports , cilt.12, ss.122-124, 2011 (Scopus)
Metrikler

Yayın

58

Yayın (WoS)

57

Yayın (Scopus)

58

H-İndeks (WoS)

20

Atıf (Scopus)

1246

H-İndeks (Scopus)

21

Tez Danışmanlığı

2

Açık Erişim

2